Mitchell Finer Buys 34,000 Shares of PepGen Inc.
Mitchell Finer acquired 34,000 shares of PepGen Inc. on June 18, 2026.
Key Points
- Mitchell Finer purchased 34,000 shares of PepGen Inc. on June 18, 2026, with shares trading near $1.79 on Tuesday.
- PepGen Inc. has a market cap of approximately $126.6 million and reported a 52-week range from $1.01 to $7.80.
- Analysts have set a mean price target of $10.25 for PepGen Inc., with a strong buy consensus from eight opinions.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Mitchell Finer, a key insider, recently acquired 34,000 shares of PepGen Inc. (NasdaqGS:PEPG) on June 18, 2026. This transaction did not occur under a pre-arranged trading plan. On Tuesday, shares of PepGen traded near $1.79.
Insider Buying and Selling at PepGen Inc.
On June 18, 2026, several insiders, including Mitchell Finer, each purchased 34,000 shares of PepGen Inc. These transactions were not part of any Rule 10b5-1 trading plan. This activity suggests confidence in the company's future prospects.
Other Institutional Activity in PepGen Inc.
Among PepGen Inc.'s institutional investors, Millennium Management LLC significantly increased its stake by 1,881,200 shares, bringing its total to 2,079,143 shares valued at approximately $3.68 million, reflecting a 950.4% increase. Commodore Capital LP also boosted its holdings by 1,075,000 shares, ending with 4,475,000 shares worth about $7.92 million, marking a 31.6% increase. Meanwhile, Laurion Capital Management LP added 698,722 shares to hold a total of 2,750,855 shares valued at around $4.87 million, representing a 34.0% increase. RA Capital Management, L.P. and Viking Global Investors LP maintained their positions without additional changes.
PepGen Inc. Stock Down 40.6%
PepGen Inc., trading on the NasdaqGS under the ticker PEPG, has a market capitalization of approximately $126.6 million. The stock's 52-week range spans from $1.01 to $7.80, with a 50-day moving average of $1.60 and a 200-day moving average of $4.05. The company, operating in the biotechnology sector, has a forward P/E of -1.49, indicating it is not currently profitable. PepGen Inc. maintains a high liquidity with a current ratio of 14.98 and a quick ratio of 14.76, but carries a debt-to-equity ratio of 12.36.
$PEPG stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On June 16, 2026, Craig-Hallum initiated coverage on PepGen Inc. with a buy rating and an $11.00 price target. Wedbush maintained its buy rating with a $4.00 target on May 13, 2026. Analysts have a strong buy consensus for PepGen, with a mean price target of $10.25 based on eight analyst opinions.
About PepGen Inc.
PepGen Inc. is a biotechnology company based in Boston, Massachusetts. It develops oligonucleotide therapeutics aimed at treating severe neuromuscular and neurologic diseases. The company is advancing its lead candidate, PGN-EDODM1, through Phase 2 clinical trials for myotonic dystrophy type 1. Founded in 2018, PepGen is led by CEO Dr. James G. McArthur, Ph.D., and employs 59 people.
Bottom Line
Mitchell Finer's recent purchase of PepGen Inc. shares highlights insider confidence in the company's future. With a strong buy recommendation from analysts and several institutional investors increasing their stakes, PepGen is a company to watch. However, investors should remember that insider transactions and 13F filings are backward-looking and may not reflect the current position.
Get PepGen Inc. alerts
New 13F filings, insider trades, and analyst moves on $PEPG, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.